ClinicalTrials.Veeva

Menu

The Role of Cervical Consistency Index and Uterocervical Angles in Medical Termination

S

Sanliurfa Mehmet Akif Inan Education and Research Hospital

Status

Completed

Conditions

Cervical Consistency Index
Uterocervical Angle
Second Trimester Abortion

Treatments

Other: abortus within 24 hours or 24-48 hours

Study type

Observational

Funder types

Other

Identifiers

NCT06164067
2011-KAEK-25 2022/04-52

Details and patient eligibility

About

The main aim of the investigator study is the success of predictivity cervical consistency index (CCI), anterior uterocervical angle (aUCA) and posterior uterocervical angle (pUCA) in second trimester terminations.

Full description

This prospective clinical study includes 136 pregnant women with a diagnosis of in utero ex fetus who were hospitalized for medical termination in the gynecology service of Health Sciences University Bursa High Specialization Training and Research Hospital Gynecology and Obstetrics Clinic as a single center. The participants were divided into 2 groups as those whose treatment was completed in the first 24 hours (who were completely aborted and removed the fetal material and its attachments ) and those who aborted within 24-48 hours when additional cycles were needed. Furthermore who applied to additional treatment methods were recorded (cervical balloon, hysterotomy ) during these periods. In all pregnant women; characteristic features, abortion times, doses of misoprostol used, anterior- posterior uterocervical angle, cervical length, cervical consistency indexes and gestational weeks were saved.

Enrollment

136 patients

Sex

Female

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • women who had a termination indication in the second trimester and had abortion or abortion in our hospital
  • women who have had a miscarriage or abortion with a normal vaginal route or hysterotomy

Exclusion criteria

  • multiple pregnancies
  • pregnant women with misoprostol-related allergies
  • scar pregnancies or heterotopic pregnancies
  • patients with a history of previous conization or cervical surgery,
  • patients with placental invasion anomaly

Trial design

136 participants in 2 patient groups

Pregnant women who abort within 24 hours
Description:
Group 1 treatment was completed in the first 24 hours ( who were completely aborted and removed the fetal material and its attachments )
Treatment:
Other: abortus within 24 hours or 24-48 hours
Pregnant women who abort within 24- 48 hours
Description:
Group 2 consisted of patients who needed additional cycles and aborted within 24-48 hours.
Treatment:
Other: abortus within 24 hours or 24-48 hours

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems